Zobrazeno 1 - 10
of 394
pro vyhledávání: '"Free prostate-specific antigen"'
Autor:
Hiroaki Iwamoto, Kouji Izumi, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
Asian Journal of Andrology, Vol 23, Iss 1, Pp 36-40 (2021)
A standard modality for prostate cancer detection in men 75 years and older has not been established. A simple screening method for elderly patients is needed to avoid unnecessary biopsies and to effectively diagnose prostate cancer. A retrospective
Externí odkaz:
https://doaj.org/article/bd5b4fbd7b9949c2adc14fe0b12f495f
Publikováno v:
Cancer Management and Research, Vol Volume 12, Pp 6821-6826 (2020)
Xiaojing Bai,1,2,* Yumei Jiang,1,2,* Xinwei Zhang,1,2 Meiyu Wang,3 Juanhua Tian,1 Lijun Mu,1 Yuefeng Du1,2 1Department of Urology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, People’s Republic of China; 2O
Externí odkaz:
https://doaj.org/article/91a55eb21d0b41be8f791ee21cf773f9
Publikováno v:
Innovative Biosystems and Bioengineering, Vol 3, Iss 4, Pp 220-231 (2019)
Background. Prostate-specific antigen (PSA) is a key marker used in the monitoring of patients with prostate hyperplasia, risk of development and cancer of prostate. Clinical laboratory diagnostics for such patients are implemented using appropriat
Externí odkaz:
https://doaj.org/article/483e7df5434048938c8ef89ac079a84f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 92, Iss 1 (2020)
Objective: In the management of benign prostatic hyperplasia (BPH), urology guide- lines recommend medical or surgical treatments according to different prostate volumes (PV). The aim of this study was to analyze the relationships between PV and age,
Externí odkaz:
https://doaj.org/article/e430000415d242b19e9decfef50a2650
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yasuhide Kitagawa, Mikio Namiki
Publikováno v:
Asian Journal of Andrology, Vol 17, Iss 3, Pp 475-480 (2015)
In Western countries, clinical trials on prostate cancer screening demonstrated a limited benefit for patient survival. In the Asia-Pacific region, including Japan, the rate of prostate-specific antigen (PSA) testing remains very low compared with We
Externí odkaz:
https://doaj.org/article/d160cbf5b36a4e70967c60b3e5262942
Autor:
Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, Li-Ping Xie, Yi-Ran Huang, Da-Lin He, Xu Gao, Chuan-Liang Xu, Qiang Ding, Qiang Wei, Chang-Jun Yin, Shan-Cheng Ren, Fu-Bo Wang, Ye Tian, Zhong-Quan Sun, Qiang Fu, Lu-Lin Ma, Jun-Hua Zheng, Zhang-Qun Ye, Ding-Wei Ye, Dan-Feng Xu, Jian-Quan Hou, Ke-Xin Xu, Jian-Lin Yuan, Xin Gao, Chun-Xiao Liu, Tie-Jun Pan, Ying-Hao Sun, on behalf of Chinese Prostate Cancer Consortium
Publikováno v:
Asian Journal of Andrology, Vol 17, Iss 6, Pp 1017-1021 (2015)
Percent free prostatic-specific antigen (%fPSA) has been introduced as a tool to avoid unnecessary biopsies in patients with a serum PSA level of 4.0-10.0 ng ml−1 , however, it remains controversial whether %fPSA is effective in PSA range of 10.1-2
Externí odkaz:
https://doaj.org/article/96a61c0ae72e4bc2bc900734591d98fe
Autor:
Renato Naito, Tomoyuki Makino, Kazuyoshi Shigehara, Hiroshi Yaegashi, Hiroaki Iwamoto, Kouji Izumi, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
Asian Journal of Andrology
Asian Journal of Andrology, Vol 23, Iss 1, Pp 36-40 (2021)
Asian Journal of Andrology, Vol 23, Iss 1, Pp 36-40 (2021)
A standard modality for prostate cancer detection in men 75 years and older has not been established. A simple screening method for elderly patients is needed to avoid unnecessary biopsies and to effectively diagnose prostate cancer. A retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927745859a24dfb08e8904fd7e8960ce
http://europepmc.org/articles/PMC7831834
http://europepmc.org/articles/PMC7831834